DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for CASI Pharmaceuticals, Inc. (CASI)
« Back to company indexCASI Chatter Timeline
Stock Ticker for CASI
Most Active Tweeters for CASI
| User | Tweets |
|---|---|
| @SwingTradeBot | 2 |
| @ConsumerFeed | 1 |
| @chaffeybreeze | 1 |
| @IRAMarketReport | 1 |
| @dispatchtribune | 1 |
Recent Tweets for CASI
 |
@OlympiaReport CASI Pharmaceuticals $CASI Share Price Passes Below 50 Day Moving Average of $3.12 https://t.co/QCCO07ugmD July 12th 2019, 9:07pm |
 |
@dispatchtribune CASI Pharmaceuticals $CASI Stock Price Passes Below 50 Day Moving Average of $3.12 https://t.co/pSzds6LCPh July 12th 2019, 9:07pm |
 |
@SwingTradeBot Rose Above Upper Bollinger Band today: $MBRX $CASI ... https://t.co/AyIukUGmib July 11th 2019, 2:07pm |
|
@SwingTradeBot Rose Above 50 DMA today: $CASI ... https://t.co/qwiJH6vr1O July 10th 2019, 3:07pm |
 |
@IRAMarketReport -$0.09 EPS Expected for CASI Pharmaceuticals Inc $CASI This Quarter https://t.co/XrlVok8Vzi #markets July 2nd 2019, 8:07pm |
 |
@chaffeybreeze -$0.09 EPS Expected for CASI Pharmaceuticals Inc $CASI This Quarter https://t.co/A0YPtX1BQV #stocks July 2nd 2019, 8:07pm |
 |
@ConsumerFeed Zacks: Brokerages Expect CASI Pharmaceuticals Inc $CASI Will Announce Earnings of -$0.09 Per Share https://t.co/bOh9hUcfnm July 2nd 2019, 8:07pm |
 |
@macondailynews CASI Pharmaceuticals $CASI Lowered to Sell at BidaskClub https://t.co/Fsdds8TzJv July 1st 2019, 3:07am |
 |
@TheMarketsDaily CASI Pharmaceuticals $CASI Lowered to Sell at BidaskClub https://t.co/O7v1Ikc6BG July 1st 2019, 3:07am |
|
@OlympiaReport Analysts Anticipate CASI Pharmaceuticals Inc $CASI Will Announce Earnings of -$0.09 Per Share https://t.co/LbZhgLtt0w June 30th 2019, 1:06pm |
 |
@WeekHerald -$0.09 Earnings Per Share Expected for CASI Pharmaceuticals Inc $CASI This Quarter https://t.co/4dIp0WrXZV June 30th 2019, 1:06pm |
 |
@midetimes BidaskClub Lowers CASI Pharmaceuticals $CASI to Sell https://t.co/KqA08pmzFP #stocks June 30th 2019, 8:06am |
 |
@dailymailtimes BidaskClub Lowers CASI Pharmaceuticals $CASI to Sell https://t.co/rTP5HWxMCI #investing June 30th 2019, 8:06am |
 |
@dailypoliticaln BidaskClub Lowers CASI Pharmaceuticals $CASI to Sell https://t.co/Txcn0mecjn June 30th 2019, 8:06am |
 |
@WatchlistN CASI Pharmaceuticals $CASI Stock Rating Lowered by BidaskClub https://t.co/X4oVTLWakL June 30th 2019, 8:06am |
 |
@CrossStocks PHRX Daily Chart: Turning bullish here Chart https://t.co/koR72KeCBP $PHRX $CASI https://t.co/qkaEPSTmGl June 29th 2019, 3:06pm |
 |
@ZolmaxNews BidaskClub Downgrades CASI Pharmaceuticals $CASI to Sell https://t.co/KnYiFtO9vj June 29th 2019, 6:06am |
 |
@ChartMill The Debt to Equity ratio for $CASI is way better than the industry averages. https://t.co/5eIoYgjPGG https://t.co/UG71V2sb6Z June 28th 2019, 3:06pm |
 |
@TickerReport CASI Pharmaceuticals $CASI Downgraded by BidaskClub to “Sell” https://t.co/zyRoMTC1Ur June 28th 2019, 9:06am |
|
@ConsumerFeed CASI Pharmaceuticals $CASI versus Surface Oncology $SURF Head-To-Head Analysis https://t.co/iXtpVolFHh June 27th 2019, 4:06am |
 |
@AmericanBanking Zacks: Analysts Anticipate CASI Pharmaceuticals Inc $CASI to Post -$0.09 Earnings Per Share https://t.co/rMBWy1Vkoq #stocks June 25th 2019, 12:06pm |
|
@TickerReport Contrasting Surface Oncology $SURF and CASI Pharmaceuticals $CASI https://t.co/rdpwAV9Qgw June 25th 2019, 3:06am |
|
@WatchlistN Zacks: CASI Pharmaceuticals Inc $CASI Receives Consensus Rating of “Strong Buy” from Analysts https://t.co/Gvdrd3u2J0 June 24th 2019, 9:06pm |
|
@midetimes Brokerages Anticipate CASI Pharmaceuticals Inc $CASI to Announce -$0.09 Earnings Per Share https://t.co/ipiHWpYHYb #stocks June 24th 2019, 9:06pm |
|
@dailymailtimes Brokerages Anticipate CASI Pharmaceuticals Inc $CASI to Announce -$0.09 Earnings Per Share https://t.co/TC9LIvJ6bv #investing June 24th 2019, 9:06pm |
|
@dailypoliticaln Brokerages Anticipate CASI Pharmaceuticals Inc $CASI to Announce -$0.09 Earnings Per Share https://t.co/9Jl6B0NmsP June 24th 2019, 9:06pm |
 |
@ZacksSmallCap $CASI Pharmaceuticals making headway towards commercialization https://t.co/BiLNf7ksA0 https://t.co/I2OMdHK77A June 24th 2019, 12:06pm |
 |
@ProVesting $BMY $CASI: Week In Review: Immunotherapies Dominate The Week’s China …: https://t.co/hWZK30EUuB June 24th 2019, 7:06am |
 |
@HeadlinesFin Is Casi Pharmaceuticals Inc $CASI a Buy? The Stock Reported more Sellers https://t.co/v3w0cRLDMQ June 23rd 2019, 9:06am |
|
@TickerReport CASI Pharmaceuticals Inc $CASI Given $7.59 Average Price Target by Brokerages https://t.co/Tv6HPgx4y8 June 22nd 2019, 9:06am |
 |
@InsiderAlertsIA $CASI: New Insider Filing on 10%+ Owner ZHOU QUAN: https://t.co/JAwMKRyS2N June 21st 2019, 5:06pm |
|
@AmericanBanking Analyzing CASI Pharmaceuticals $CASI & Surface Oncology $SURF https://t.co/iflW7P4pRg #stocks June 20th 2019, 6:06pm |
 |
@smallcapwatch RT @ahighelevation: $CASI Pharmaceuticals making headway towards commercialization #biotech #smallcap https://t.co/FiO5nlIdRu https://t.co/… June 20th 2019, 1:06pm |
 |
@ahighelevation $CASI Pharmaceuticals making headway towards commercialization #biotech #smallcap https://t.co/FiO5nlIdRu https://t.co/Fk3TXWefok June 20th 2019, 1:06pm |
|
@TickerReport Head to Head Review: CASI Pharmaceuticals $CASI and Jounce Therapeutics $JNCE https://t.co/kEwD1lnBYy June 19th 2019, 8:06pm |
 |
@1stOncology #CASIPharmaceuticals Acquires Worldwide Rights To Commercialize #antiCD19TCellTherapy $CASI https://t.co/UYtvoNBeSZ June 19th 2019, 8:06am |
|
@AmericanBanking Head-To-Head Comparison: Oncobiologics $ONS and CASI Pharmaceuticals $CASI https://t.co/Mjhc5aiiAg #stocks June 19th 2019, 4:06am |
 |
@fintel_io $CASI / CASI Pharmaceuticals files form 8-K https://t.co/HsbVnLByxj - Entry into a Material Definitive Agreement, F… https://t.co/Ms4YbIvL7J June 18th 2019, 4:06pm |
|
@AmericanBanking Zacks: CASI Pharmaceuticals Inc $CASI Given $7.59 Average Price Target by Analysts https://t.co/vtgvBgjRaG #stocks June 18th 2019, 12:06am |
 |
@MaisaCorp $CASI has signed an agreement for the exclusive worldwide license and commercialization rights to an autologous an… https://t.co/ROT7MfkYbl June 17th 2019, 5:06pm |
 |
@StockNewsNow $CASI CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy https://t.co/wCEjWwjhwL June 17th 2019, 12:06pm |
 |
@NewsQuantified $CASI Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy, Stock jumps +14.65% #CASIPharmaceuticals https://t.co/H9jyNsM5yv June 17th 2019, 9:06am |
 |
@trentkelp RT @OpenOutcrier: $CASI (+9.9% pre) CASI Pharma (CASI) Reports Acquisition of Worldwide Rights To Commercialize anti-CD19 T-cell Therapy -… June 17th 2019, 9:06am |
 |
@Briefingcom $CASI: CASI Pharma signs license agreement for exclusive worldwide license and commercialization rights to an... https://t.co/jcZ0iw9uNh June 17th 2019, 9:06am |
 |
@OpenOutcrier $CASI (+9.9% pre) CASI Pharma (CASI) Reports Acquisition of Worldwide Rights To Commercialize anti-CD19 T-cell Ther… https://t.co/Hp70sNgTpy June 17th 2019, 8:06am |
 |
@startupxfactor RT @MarketCurrents: $CASI - CASI in-licenses rights to anti-CD19 T-cell therapy; shares up 5% premarket https://t.co/4W1zi5eCgw June 17th 2019, 7:06am |
 |
@MarketCurrents $CASI - CASI in-licenses rights to anti-CD19 T-cell therapy; shares up 5% premarket https://t.co/4W1zi5eCgw June 17th 2019, 7:06am |
 |
@ez_alertz $CASI CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy https://t.co/oU3rg4LeVG June 17th 2019, 7:06am |
 |
@CHItraders $CASI Pharma Acquires Worldwide Rights to Commercialize Anti-CD19 T-Cell Therapy From Juventas Cell Therapy, CASI t… https://t.co/mjDfd4NaiV June 17th 2019, 7:06am |
 |
@ThisLincolnian CASI Pharmaceuticals $CASI Stock Rating Upgraded by BidaskClub https://t.co/FFhmiLZYUP June 17th 2019, 3:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.